The TFPI-2 Derived Peptide EDC34 Improves Outcome of Gram-Negative Sepsis

• Praveen Papareddy ,

  * E-mail: praveen.papareddy@med.lu.se

  Affiliation Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden

  ⨯
• Martina Kalle,

  Affiliation Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden

  ⨯
• Ole E. Sørensen,

  Affiliation Division of Infection Medicine, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden

  ⨯
• Martin Malmsten,

  Affiliation Department of Pharmacy, Uppsala University, Uppsala, Sweden

  ⨯
• Matthias Mörgelin,

  Affiliation Division of Infection Medicine, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden

  ⨯
• Artur Schmidtchen

  Affiliations Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore

  ⨯